More from Author Ben Oakley here: https://globelivemedia.com/author/ben-oakley/
In the last 24 hours, 4,001 vaccines were applied out of the 219,375 doses that the country received. (Photo: EFE / Miguel Sierra)
Vaccination against the SARS-CoV-2 virus has been one of the health priorities of the Mexican government since it began on December 24, 2020. Until the last daily cut, 498,122 doses have been applied to health workers who directly treat the disease, reported the federal Ministry of Health.
Undersecretary Hugo López-Gatell specified that of the total number of immunized people, 488,513 received the first dose, while another 9,609 received their booster.
In the last 24 hours, 4,001 vaccines were applied out of the 219,375 doses that the country received. However, the authorities, through the Technical Advisory Group on Immunization, They analyze whether the period of application of the reinforcement will be extended to 21, 28 or up to 42 days, as recently recommended by the World Health Organization.
Regarding the reactions to the vaccine from the Pfizer laboratories, López-Gatell said that 2,048 events supposedly attributable to immunization have been reported, of which only 29 have been considered serious. Of these only three had to be hospitalized for presenting anaphylactic shocks.
In Mexico, 233,385 doses have been distributed in the 32 entities of the country through 11 categories of health workers (Photo: Cuartoscuro)
Seven of these patients reside in Coahuila, four in Mexico City, two in Oaxaca, Tabasco, Chihuahua, the State of Mexico and Guanajuato. The places where only one person had a reaction to the dose were Michoacán, Nuevo León, San Luis Potosí, Baja California Sur, Hidalgo and Jalisco.
The Events Supposedly Attributable to Vaccination and Immunization (Esavis) appeared in 22 women and seven men, which means that there is 0.4% of reactions among the vaccines applied at the national level.
In Mexico 233,385 doses have been distributed in the 32 entities of the country through 11 categories of health workers treating COVID-19 disease on the front line.
Currently, the doses applied belong to Pfizer laboratories; however, the country has three other agreements to obtain the antidote against SARS-CoV-2. In fact, The arrival of the first shipment with the active ingredient of the Oxford Astrazeneca vaccine is expected on January 20 that left Buenos Aires, Argentina, bound for Mexico.
Mexico has registered 1 million 668,399 positive cases of COVID-19 and 142,832 deaths from the disease. (Photo: Cuartoscuro)
On January 17, the government of Andrés Manuel López Obrador (AMLO) announced that it would a temporary interruption of Pfizer supplies at the request of the United Nations (UN). This with the aim of avoiding the hoarding of the antidote and favoring that poor countries can be immunized.
The UN “is demanding (to Pfizer) to deliver vaccines so that it can offer them to countries that have a harder time getting them. So that’s why Pfizer is reducing delivery”Reported the president in a morning conference
However, the Secretary of Finance and Public Credit, Arturo Herrera Gutiérrez, pointed out that This does not imply a shortage of the inoculant doses, as this will be replaced with the other signed vaccination agreements, among them that of the Chinese CanSino laboratories and that of Sputnik, developed in Russia. In this way, the country intends to obtain more than 12 million doses.
Currently, Mexico has registered 1 million 668,399 positive cases of COVID-19 and 142,832 deaths from the disease. Of these 1,584 people died and 18,897 became infected in the last 24 hours.